Drug Search Results

Udenafil

Alternative Names: udenafil, zydena, da-8159, mz-101, mz101, mz 101
Latest Update: 2024-03-01
Latest Update Note: News Article

Product Description

Mechanisms of Action: PDE5 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Dong-A
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Udenafil

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Other

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
FUEL-2	P3	Recruiting	Other	2025-10-28

Recent News Events

Date	Type	Title
04/16/2025	News Article	New ICD-10 Codes Recognize Fontan-Associated Conditions, Advancing Care and Coverage for Rare Congenital Heart Disease Community
03/01/2024	News Article	Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2
01/17/2024	PubMed	Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders.
01/01/2024	PubMed	The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation.
11/30/2023	PubMed	Postmicturition dribble in men with no previous urogenital surgery: Systematic review and meta-analysis of treatment modalities.
09/25/2023	News Article	Erectile Dysfunction Market Research Report 2023-2031
09/21/2023	News Article	Erectile Dysfunction Drugs Market Outlook for Forecast Period (2023 to 2030)

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions